English

Sunovion Pharmaceuticals Inc.

EDGAR

Quarterly report (10-Q) · filed 2009-08-05

70 filing records in this dataset, filed from 1996-05-14 to 2009-08-05. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

326 million USD

2009-06-30 · USD

Exact inputs and evidence

Revenue: 326244000 USD Source

Operating margin

22.48%

2009-06-30 · %

Exact inputs and evidence

Operating Income: 73337000 USD Source
Revenue: 326244000 USD Source

Cash and cash equivalents: 367 million USD 2009-06-30 Source
Exact value

367234000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

1.33 billion USD

2008-07-01 – 2009-06-30

Exact inputs and evidence

Revenue: 307673000 USD · 2008-07-01 – 2008-09-30 Source
Revenue: 1292289000 USD · 2008-01-01 – 2008-12-31 Source
Revenue: 922597000 USD · 2008-01-01 – 2008-09-30 Source
Revenue: 330172000 USD · 2009-01-01 – 2009-03-31 Source
Revenue: 326244000 USD · 2009-04-01 – 2009-06-30 Source

Net income

188 million USD

2008-07-01 – 2009-06-30

Exact inputs and evidence

Net income: 19438000 USD · 2008-07-01 – 2008-09-30 Source
Net income: 515110000 USD · 2008-01-01 – 2008-12-31 Source
Net income: 426710000 USD · 2008-01-01 – 2008-09-30 Source
Net income: 35177000 USD · 2009-01-01 – 2009-03-31 Source
Net income: 44850000 USD · 2009-04-01 – 2009-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2009-08-05.

Financial data available through: 2008-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2008-12-31
Operating income: 11 of 11 periods available· newest 2008-12-31
Net income: 11 of 11 periods available· newest 2008-12-31
Operating cash flow: 10 of 11 periods available· newest 2008-12-31
Capital expenditure: 10 of 11 periods available· newest 2008-12-31
Total assets: 11 of 11 periods available· newest 2008-12-31
Total liabilities: 11 of 11 periods available· newest 2008-12-31
Current assets: 11 of 11 periods available· newest 2008-12-31
Current liabilities: 11 of 11 periods available· newest 2008-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2008-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+5.5%

Prior period

USD 1.23 billion

2007-01-01 – 2007-12-31
Current period

USD 1.29 billion

2008-01-01 – 2008-12-31

Exact inputs and evidence

1292289000 − 1225230000 = 67059000 USD

1225230000 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
1292289000 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Sunovion Pharmaceuticals Inc. · 2008-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Year-over-year change in Revenue: 67059000 USD Concept: fundies:Revenue Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 1292289000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-09-001949.txt#11112 Input fundies:Revenue: 1225230000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-09-001949.txt#11112
The citation records this snapshot. The page link may show a newer release later.
Net income
+783.1%

Prior period

USD 58.33 million

2007-01-01 – 2007-12-31
Current period

USD 515.11 million

2008-01-01 – 2008-12-31

Exact inputs and evidence

515110000 − 58333000 = 456777000 USD

58333000 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
515110000 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Sunovion Pharmaceuticals Inc. · 2008-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Year-over-year change in Net income: 456777000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 515110000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-09-001949.txt#12646 Input fundies:NetIncome: 58333000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-09-001949.txt#12646
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-49.8%

Prior period

USD 324 million

2007-01-01 – 2007-12-31
Current period

USD 162.76 million

2008-01-01 – 2008-12-31

Exact inputs and evidence

162757000 − 324000000 = -161243000 USD

324000000 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
162757000 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Sunovion Pharmaceuticals Inc. · 2008-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Year-over-year change in Operating cash flow: -161243000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 162757000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-09-001949.txt#12920 Input fundies:OperatingCashFlow: 324000000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-09-001949.txt#12920
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+95%

Prior period

USD 25.45 million

2007-01-01 – 2007-12-31
Current period

USD 49.62 million

2008-01-01 – 2008-12-31

Exact inputs and evidence

49615000 − 25450000 = 24165000 USD

25450000 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
49615000 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Sunovion Pharmaceuticals Inc. · 2008-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Year-over-year change in Capital expenditure: 24165000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 49615000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-09-001949.txt#13026 Input fundies:CapitalExpenditure: 25450000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-09-001949.txt#13026
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2008 2008-01-01 – 2008-12-31

Revenue USD 1.29 billion 100% of revenue
Operating costs Derived USD 1.24 billion 96% of revenue
Operating income USD 55.73 million 4.3% of revenue
Tax, interest and other Derived −USD 459.38 million −36% of revenue
Net income USD 515.11 million 40% of revenue

Cash

Operating cash flow USD 162.76 million 13% of revenue
Capital expenditure USD 49.62 million 3.8% of revenue
Free cash flow Derived USD 113.14 million 8.8% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1999 Operating loss: operating costs were 850% of revenue.
2000 Operating loss: operating costs were 333% of revenue.
2001 Operating loss: operating costs were 249% of revenue.
2002 Operating loss: operating costs were 187% of revenue.
2003 Operating loss: operating costs were 130% of revenue.
2004 Operating loss: operating costs were 154% of revenue.
2005 Operating loss: operating costs were 105% of revenue.
2006 Net income was higher than operating income, so the split is not drawn.
2007 Net income was higher than operating income, so the split is not drawn.
2008 Net income was higher than operating income, so the split is not drawn.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1999 1999-01-01 – 1999-12-31	22659000	192655000 Derived	-169996000	13063000 Derived	-183059000	Unavailable	Source 1999-01-01 – 1999-12-31: 22659000 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -169996000 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -183059000 USD Inspect Net Income Open source
2000 2000-01-01 – 2000-12-31	85245000	283491000 Derived	-198246000	5771000 Derived	-204017000	-179780000 Derived	Source 2000-01-01 – 2000-12-31: 85245000 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -198246000 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -204017000 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -170943000 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 8837000 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	152095000	378568000 Derived	-226473000	-2458000 Derived	-224015000	-238607000 Derived	Source 2001-01-01 – 2001-12-31: 152095000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -226473000 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -224015000 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -209919000 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 28688000 USD Inspect Capital Expenditure Open source
2002 2002-01-01 – 2002-12-31	238968000	446269000 Derived	-207301000	69189000 Derived	-276490000	-285084000 Derived	Source 2002-01-01 – 2002-12-31: 238968000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -207301000 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -276490000 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -246922000 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 38162000 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	344040000	447363000 Derived	-103323000	34599000 Derived	-137922000	-109043000 Derived	Source 2003-01-01 – 2003-12-31: 344040000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -103323000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -137922000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -104351000 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 4692000 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	380877000	584818000 Derived	-203941000	92969000 Derived	-296910000	-194722000 Derived	Source 2004-01-01 – 2004-12-31: 380877000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -203941000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -296910000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -183329000 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 11393000 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	801108000	838545000 Derived	-37437000	-21544000 Derived	-15893000	-36345000 Derived	Source 2005-01-01 – 2005-12-31: 801108000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -37437000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -15893000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -22617000 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 13728000 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	1183133000	1032017000 Derived	151116000	-20045000 Derived	171161000	162992000 Derived	Source 2006-01-01 – 2006-12-31: 1183133000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: 151116000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: 171161000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: 178888000 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 15896000 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	1225230000	1202697000 Derived	22533000	-35800000 Derived	58333000	298550000 Derived	Source 2007-01-01 – 2007-12-31: 1225230000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: 22533000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: 58333000 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: 324000000 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 25450000 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	1292289000	1236562000 Derived	55727000	-459383000 Derived	515110000	113142000 Derived	Source 2008-01-01 – 2008-12-31: 1292289000 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: 55727000 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: 515110000 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: 162757000 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 49615000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 1.3B 2008

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19991999-12-31	Revenue	22659000	Revenue: 22659000 Open source
20002000-12-31	Revenue	85245000	Revenue: 85245000 Open source
20012001-12-31	Revenue	152095000	Revenue: 152095000 Open source
20022002-12-31	Revenue	238968000	Revenue: 238968000 Open source
20032003-12-31	Revenue	344040000	Revenue: 344040000 Open source
20042004-12-31	Revenue	380877000	Revenue: 380877000 Open source
20052005-12-31	Revenue	801108000	Revenue: 801108000 Open source
20062006-12-31	Revenue	1183133000	Revenue: 1183133000 Open source
20072007-12-31	Revenue	1225230000	Revenue: 1225230000 Open source
20082008-12-31	Revenue	1292289000	Revenue: 1292289000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

5.5% 2008

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19991999-12-31	Year over year	122%	Revenue: 22659000 Open source Revenue: 10209000 Open source
20002000-12-31	Year over year	276.2%	Revenue: 85245000 Open source Revenue: 22659000 Open source
20012001-12-31	Year over year	78.4%	Revenue: 152095000 Open source Revenue: 85245000 Open source
20022002-12-31	Year over year	57.1%	Revenue: 238968000 Open source Revenue: 152095000 Open source
20032003-12-31	Year over year	44%	Revenue: 344040000 Open source Revenue: 238968000 Open source
20042004-12-31	Year over year	10.7%	Revenue: 380877000 Open source Revenue: 344040000 Open source
20052005-12-31	Year over year	110.3%	Revenue: 801108000 Open source Revenue: 380877000 Open source
20062006-12-31	Year over year	47.7%	Revenue: 1183133000 Open source Revenue: 801108000 Open source
20072007-12-31	Year over year	3.6%	Revenue: 1225230000 Open source Revenue: 1183133000 Open source
20082008-12-31	Year over year	5.5%	Revenue: 1292289000 Open source Revenue: 1225230000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 4.3% 2008

Net margin 39.9% 2008

Free cash flow margin 8.8% 2008

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19991999-12-31	Operating margin	-750.2%	Operating Income: -169996000 Open source Revenue: 22659000 Open source
20002000-12-31	Operating margin	-232.6%	Operating Income: -198246000 Open source Revenue: 85245000 Open source
20012001-12-31	Operating margin	-148.9%	Operating Income: -226473000 Open source Revenue: 152095000 Open source
20022002-12-31	Operating margin	-86.7%	Operating Income: -207301000 Open source Revenue: 238968000 Open source
20032003-12-31	Operating margin	-30%	Operating Income: -103323000 Open source Revenue: 344040000 Open source
20042004-12-31	Operating margin	-53.5%	Operating Income: -203941000 Open source Revenue: 380877000 Open source
20052005-12-31	Operating margin	-4.7%	Operating Income: -37437000 Open source Revenue: 801108000 Open source
20062006-12-31	Operating margin	12.8%	Operating Income: 151116000 Open source Revenue: 1183133000 Open source
20072007-12-31	Operating margin	1.8%	Operating Income: 22533000 Open source Revenue: 1225230000 Open source
20082008-12-31	Operating margin	4.3%	Operating Income: 55727000 Open source Revenue: 1292289000 Open source
19991999-12-31	Net margin	-807.9%	Net Income: -183059000 Open source Revenue: 22659000 Open source
20002000-12-31	Net margin	-239.3%	Net Income: -204017000 Open source Revenue: 85245000 Open source
20012001-12-31	Net margin	-147.3%	Net Income: -224015000 Open source Revenue: 152095000 Open source
20022002-12-31	Net margin	-115.7%	Net Income: -276490000 Open source Revenue: 238968000 Open source
20032003-12-31	Net margin	-40.1%	Net Income: -137922000 Open source Revenue: 344040000 Open source
20042004-12-31	Net margin	-78%	Net Income: -296910000 Open source Revenue: 380877000 Open source
20052005-12-31	Net margin	-2%	Net Income: -15893000 Open source Revenue: 801108000 Open source
20062006-12-31	Net margin	14.5%	Net Income: 171161000 Open source Revenue: 1183133000 Open source
20072007-12-31	Net margin	4.8%	Net Income: 58333000 Open source Revenue: 1225230000 Open source
20082008-12-31	Net margin	39.9%	Net Income: 515110000 Open source Revenue: 1292289000 Open source
19991999-12-31	Free cash flow margin	Not reported	Revenue: 22659000 Open source
20002000-12-31	Free cash flow margin	-210.9%	Revenue: 85245000 Open source Operating Cash Flow: -170943000 Open source Capital Expenditure: 8837000 Open source
20012001-12-31	Free cash flow margin	-156.9%	Revenue: 152095000 Open source Operating Cash Flow: -209919000 Open source Capital Expenditure: 28688000 Open source
20022002-12-31	Free cash flow margin	-119.3%	Revenue: 238968000 Open source Operating Cash Flow: -246922000 Open source Capital Expenditure: 38162000 Open source
20032003-12-31	Free cash flow margin	-31.7%	Revenue: 344040000 Open source Operating Cash Flow: -104351000 Open source Capital Expenditure: 4692000 Open source
20042004-12-31	Free cash flow margin	-51.1%	Revenue: 380877000 Open source Operating Cash Flow: -183329000 Open source Capital Expenditure: 11393000 Open source
20052005-12-31	Free cash flow margin	-4.5%	Revenue: 801108000 Open source Operating Cash Flow: -22617000 Open source Capital Expenditure: 13728000 Open source
20062006-12-31	Free cash flow margin	13.8%	Revenue: 1183133000 Open source Operating Cash Flow: 178888000 Open source Capital Expenditure: 15896000 Open source
20072007-12-31	Free cash flow margin	24.4%	Revenue: 1225230000 Open source Operating Cash Flow: 324000000 Open source Capital Expenditure: 25450000 Open source
20082008-12-31	Free cash flow margin	8.8%	Revenue: 1292289000 Open source Operating Cash Flow: 162757000 Open source Capital Expenditure: 49615000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 162.8M 2008

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19991999-12-31	Operating cash flow	Not reported	No source recorded
20002000-12-31	Operating cash flow	-170943000	Operating Cash Flow: -170943000 Open source
20012001-12-31	Operating cash flow	-209919000	Operating Cash Flow: -209919000 Open source
20022002-12-31	Operating cash flow	-246922000	Operating Cash Flow: -246922000 Open source
20032003-12-31	Operating cash flow	-104351000	Operating Cash Flow: -104351000 Open source
20042004-12-31	Operating cash flow	-183329000	Operating Cash Flow: -183329000 Open source
20052005-12-31	Operating cash flow	-22617000	Operating Cash Flow: -22617000 Open source
20062006-12-31	Operating cash flow	178888000	Operating Cash Flow: 178888000 Open source
20072007-12-31	Operating cash flow	324000000	Operating Cash Flow: 324000000 Open source
20082008-12-31	Operating cash flow	162757000	Operating Cash Flow: 162757000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 113.1M 2008

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19991999-12-31	Free cash flow	Unavailable	No source recorded
20002000-12-31	Free cash flow	-179780000	Operating Cash Flow: -170943000 Open source Capital Expenditure: 8837000 Open source
20012001-12-31	Free cash flow	-238607000	Operating Cash Flow: -209919000 Open source Capital Expenditure: 28688000 Open source
20022002-12-31	Free cash flow	-285084000	Operating Cash Flow: -246922000 Open source Capital Expenditure: 38162000 Open source
20032003-12-31	Free cash flow	-109043000	Operating Cash Flow: -104351000 Open source Capital Expenditure: 4692000 Open source
20042004-12-31	Free cash flow	-194722000	Operating Cash Flow: -183329000 Open source Capital Expenditure: 11393000 Open source
20052005-12-31	Free cash flow	-36345000	Operating Cash Flow: -22617000 Open source Capital Expenditure: 13728000 Open source
20062006-12-31	Free cash flow	162992000	Operating Cash Flow: 178888000 Open source Capital Expenditure: 15896000 Open source
20072007-12-31	Free cash flow	298550000	Operating Cash Flow: 324000000 Open source Capital Expenditure: 25450000 Open source
20082008-12-31	Free cash flow	113142000	Operating Cash Flow: 162757000 Open source Capital Expenditure: 49615000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

59.9% 2008

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
19991999-12-31	Liabilities / assets	138.1%	Total Liabilities: 561406000 Open source Total Assets: 406635000 Open source
20002000-12-31	Liabilities / assets	127.6%	Total Liabilities: 958573000 Open source Total Assets: 750958000 Open source
20012001-12-31	Liabilities / assets	128.7%	Total Liabilities: 1407233000 Open source Total Assets: 1093531000 Open source
20022002-12-31	Liabilities / assets	153.9%	Total Liabilities: 1119293000 Open source Total Assets: 727113000 Open source
20032003-12-31	Liabilities / assets	160.7%	Total Liabilities: 1639436000 Open source Total Assets: 1020225000 Open source
20042004-12-31	Liabilities / assets	131.9%	Total Liabilities: 1370233000 Open source Total Assets: 1039118000 Open source
20052005-12-31	Liabilities / assets	113%	Total Liabilities: 1439986000 Open source Total Assets: 1274497000 Open source
20062006-12-31	Liabilities / assets	97.3%	Total Liabilities: 1453609000 Open source Total Assets: 1493793000 Open source
20072007-12-31	Liabilities / assets	87.4%	Total Liabilities: 1228313000 Open source Total Assets: 1404726000 Open source
20082008-12-31	Liabilities / assets	59.9%	Total Liabilities: 1082685000 Open source Total Assets: 1807324000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.3× 2008

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19991999-12-31	Current assets / current liabilities	4.9×	Current Assets: 342562000 Open source Current Liabilities: 69969000 Open source
20002000-12-31	Current assets / current liabilities	6.04×	Current Assets: 628842000 Open source Current Liabilities: 104179000 Open source
20012001-12-31	Current assets / current liabilities	5.99×	Current Assets: 872973000 Open source Current Liabilities: 145837000 Open source
20022002-12-31	Current assets / current liabilities	4.03×	Current Assets: 549968000 Open source Current Liabilities: 136441000 Open source
20032003-12-31	Current assets / current liabilities	1.43×	Current Assets: 854252000 Open source Current Liabilities: 598428000 Open source
20042004-12-31	Current assets / current liabilities	4.12×	Current Assets: 839930000 Open source Current Liabilities: 204110000 Open source
20052005-12-31	Current assets / current liabilities	3.77×	Current Assets: 1046545000 Open source Current Liabilities: 277906000 Open source
20062006-12-31	Current assets / current liabilities	1.67×	Current Assets: 1221028000 Open source Current Liabilities: 732096000 Open source
20072007-12-31	Current assets / current liabilities	2.04×	Current Assets: 1131305000 Open source Current Liabilities: 554114000 Open source
20082008-12-31	Current assets / current liabilities	1.3×	Current Assets: 1092427000 Open source Current Liabilities: 840874000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1999 1999-01-01 – 1999-12-31	−USD 183.06 million Exact value Exact value: -183059000 USD 1999-01-01 – 1999-12-31: -183059000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Sunovion Pharmaceuticals Inc. · 1999-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Net Income: -183059000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -183059000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0000912057-02-012777.txt#10398 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2000 2000-01-01 – 2000-12-31	−USD 204.02 million Exact value Exact value: -204017000 USD 2000-01-01 – 2000-12-31: -204017000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Sunovion Pharmaceuticals Inc. · 2000-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Net Income: -204017000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -204017000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-03-011214.txt#10702 The citation records this snapshot. The page link may show a newer release later.	−USD 170.94 million Exact value Exact value: -170943000 USD 2000-01-01 – 2000-12-31: -170943000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Sunovion Pharmaceuticals Inc. · 2000-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Operating Cash Flow: -170943000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -170943000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-03-011214.txt#10962 The citation records this snapshot. The page link may show a newer release later.	USD 8.84 million Exact value Exact value: 8837000 USD 2000-01-01 – 2000-12-31: 8837000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Sunovion Pharmaceuticals Inc. · 2000-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Capital Expenditure: 8837000 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8837000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-03-011214.txt#11016 The citation records this snapshot. The page link may show a newer release later.	−USD 179.78 million Calculation and evidence -170943000 − 8837000 USD Exact free cash flow: -179780000 USD 2000-01-01 – 2000-12-31: -170943000 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 8837000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Sunovion Pharmaceuticals Inc. · 2000-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Free cash flow: -179780000 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -170943000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-03-011214.txt#10962 Input fundies:CapitalExpenditure: 8837000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-03-011214.txt#11016 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 224.02 million Exact value Exact value: -224015000 USD 2001-01-01 – 2001-12-31: -224015000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Sunovion Pharmaceuticals Inc. · 2001-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Net Income: -224015000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -224015000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-04-007784.txt#9524 The citation records this snapshot. The page link may show a newer release later.	−USD 209.92 million Exact value Exact value: -209919000 USD 2001-01-01 – 2001-12-31: -209919000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Sunovion Pharmaceuticals Inc. · 2001-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Operating Cash Flow: -209919000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -209919000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-04-007784.txt#9798 The citation records this snapshot. The page link may show a newer release later.	USD 28.69 million Exact value Exact value: 28688000 USD 2001-01-01 – 2001-12-31: 28688000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Sunovion Pharmaceuticals Inc. · 2001-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Capital Expenditure: 28688000 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 28688000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-04-007784.txt#9852 The citation records this snapshot. The page link may show a newer release later.	−USD 238.61 million Calculation and evidence -209919000 − 28688000 USD Exact free cash flow: -238607000 USD 2001-01-01 – 2001-12-31: -209919000 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 28688000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Sunovion Pharmaceuticals Inc. · 2001-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Free cash flow: -238607000 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -209919000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-04-007784.txt#9798 Input fundies:CapitalExpenditure: 28688000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-04-007784.txt#9852 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	−USD 276.49 million Exact value Exact value: -276490000 USD 2002-01-01 – 2002-12-31: -276490000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Sunovion Pharmaceuticals Inc. · 2002-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Net Income: -276490000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -276490000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-05-006711.txt#10911 The citation records this snapshot. The page link may show a newer release later.	−USD 246.92 million Exact value Exact value: -246922000 USD 2002-01-01 – 2002-12-31: -246922000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Sunovion Pharmaceuticals Inc. · 2002-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Operating Cash Flow: -246922000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -246922000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-05-006711.txt#11171 The citation records this snapshot. The page link may show a newer release later.	USD 38.16 million Exact value Exact value: 38162000 USD 2002-01-01 – 2002-12-31: 38162000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Sunovion Pharmaceuticals Inc. · 2002-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Capital Expenditure: 38162000 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 38162000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-05-006711.txt#11225 The citation records this snapshot. The page link may show a newer release later.	−USD 285.08 million Calculation and evidence -246922000 − 38162000 USD Exact free cash flow: -285084000 USD 2002-01-01 – 2002-12-31: -246922000 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 38162000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Sunovion Pharmaceuticals Inc. · 2002-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Free cash flow: -285084000 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -246922000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-05-006711.txt#11171 Input fundies:CapitalExpenditure: 38162000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-05-006711.txt#11225 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 137.92 million Exact value Exact value: -137922000 USD 2003-01-01 – 2003-12-31: -137922000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Sunovion Pharmaceuticals Inc. · 2003-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Net Income: -137922000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -137922000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-06-011745.txt#8496 The citation records this snapshot. The page link may show a newer release later.	−USD 104.35 million Exact value Exact value: -104351000 USD 2003-01-01 – 2003-12-31: -104351000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Sunovion Pharmaceuticals Inc. · 2003-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Operating Cash Flow: -104351000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -104351000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-06-011745.txt#8756 The citation records this snapshot. The page link may show a newer release later.	USD 4.69 million Exact value Exact value: 4692000 USD 2003-01-01 – 2003-12-31: 4692000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Sunovion Pharmaceuticals Inc. · 2003-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Capital Expenditure: 4692000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4692000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-06-011745.txt#8820 The citation records this snapshot. The page link may show a newer release later.	−USD 109.04 million Calculation and evidence -104351000 − 4692000 USD Exact free cash flow: -109043000 USD 2003-01-01 – 2003-12-31: -104351000 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 4692000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Sunovion Pharmaceuticals Inc. · 2003-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Free cash flow: -109043000 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -104351000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-06-011745.txt#8756 Input fundies:CapitalExpenditure: 4692000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-06-011745.txt#8820 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 296.91 million Exact value Exact value: -296910000 USD 2004-01-01 – 2004-12-31: -296910000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Sunovion Pharmaceuticals Inc. · 2004-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Net Income: -296910000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -296910000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001104659-07-015609.txt#18266 The citation records this snapshot. The page link may show a newer release later.	−USD 183.33 million Exact value Exact value: -183329000 USD 2004-01-01 – 2004-12-31: -183329000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Sunovion Pharmaceuticals Inc. · 2004-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Operating Cash Flow: -183329000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -183329000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001104659-07-015609.txt#18724 The citation records this snapshot. The page link may show a newer release later.	USD 11.39 million Exact value Exact value: 11393000 USD 2004-01-01 – 2004-12-31: 11393000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Sunovion Pharmaceuticals Inc. · 2004-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Capital Expenditure: 11393000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 11393000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001104659-07-015609.txt#18831 The citation records this snapshot. The page link may show a newer release later.	−USD 194.72 million Calculation and evidence -183329000 − 11393000 USD Exact free cash flow: -194722000 USD 2004-01-01 – 2004-12-31: -183329000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 11393000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Sunovion Pharmaceuticals Inc. · 2004-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Free cash flow: -194722000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -183329000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001104659-07-015609.txt#18724 Input fundies:CapitalExpenditure: 11393000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001104659-07-015609.txt#18831 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 15.89 million Exact value Exact value: -15893000 USD 2005-01-01 – 2005-12-31: -15893000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Sunovion Pharmaceuticals Inc. · 2005-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Net Income: -15893000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15893000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-08-002053.txt#11080 The citation records this snapshot. The page link may show a newer release later.	−USD 22.62 million Exact value Exact value: -22617000 USD 2005-01-01 – 2005-12-31: -22617000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Sunovion Pharmaceuticals Inc. · 2005-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Operating Cash Flow: -22617000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -22617000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-08-002053.txt#11326 The citation records this snapshot. The page link may show a newer release later.	USD 13.73 million Exact value Exact value: 13728000 USD 2005-01-01 – 2005-12-31: 13728000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Sunovion Pharmaceuticals Inc. · 2005-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Capital Expenditure: 13728000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13728000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-08-002053.txt#11390 The citation records this snapshot. The page link may show a newer release later.	−USD 36.35 million Calculation and evidence -22617000 − 13728000 USD Exact free cash flow: -36345000 USD 2005-01-01 – 2005-12-31: -22617000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 13728000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Sunovion Pharmaceuticals Inc. · 2005-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Free cash flow: -36345000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -22617000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-08-002053.txt#11326 Input fundies:CapitalExpenditure: 13728000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-08-002053.txt#11390 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	USD 171.16 million Exact value Exact value: 171161000 USD 2006-01-01 – 2006-12-31: 171161000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Sunovion Pharmaceuticals Inc. · 2006-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Net Income: 171161000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: 171161000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-09-001949.txt#12646 The citation records this snapshot. The page link may show a newer release later.	USD 178.89 million Exact value Exact value: 178888000 USD 2006-01-01 – 2006-12-31: 178888000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Sunovion Pharmaceuticals Inc. · 2006-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Operating Cash Flow: 178888000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 178888000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-09-001949.txt#12920 The citation records this snapshot. The page link may show a newer release later.	USD 15.9 million Exact value Exact value: 15896000 USD 2006-01-01 – 2006-12-31: 15896000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Sunovion Pharmaceuticals Inc. · 2006-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Capital Expenditure: 15896000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 15896000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-09-001949.txt#13026 The citation records this snapshot. The page link may show a newer release later.	USD 162.99 million Calculation and evidence 178888000 − 15896000 USD Exact free cash flow: 162992000 USD 2006-01-01 – 2006-12-31: 178888000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 15896000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Sunovion Pharmaceuticals Inc. · 2006-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Free cash flow: 162992000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 178888000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-09-001949.txt#12920 Input fundies:CapitalExpenditure: 15896000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-09-001949.txt#13026 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	USD 58.33 million Exact value Exact value: 58333000 USD 2007-01-01 – 2007-12-31: 58333000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Sunovion Pharmaceuticals Inc. · 2007-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Net Income: 58333000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: 58333000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-09-001949.txt#12646 The citation records this snapshot. The page link may show a newer release later.	USD 324 million Exact value Exact value: 324000000 USD 2007-01-01 – 2007-12-31: 324000000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Sunovion Pharmaceuticals Inc. · 2007-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Operating Cash Flow: 324000000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 324000000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-09-001949.txt#12920 The citation records this snapshot. The page link may show a newer release later.	USD 25.45 million Exact value Exact value: 25450000 USD 2007-01-01 – 2007-12-31: 25450000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Sunovion Pharmaceuticals Inc. · 2007-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Capital Expenditure: 25450000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 25450000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-09-001949.txt#13026 The citation records this snapshot. The page link may show a newer release later.	USD 298.55 million Calculation and evidence 324000000 − 25450000 USD Exact free cash flow: 298550000 USD 2007-01-01 – 2007-12-31: 324000000 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 25450000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Sunovion Pharmaceuticals Inc. · 2007-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Free cash flow: 298550000 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 324000000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-09-001949.txt#12920 Input fundies:CapitalExpenditure: 25450000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-09-001949.txt#13026 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	USD 515.11 million Exact value Exact value: 515110000 USD 2008-01-01 – 2008-12-31: 515110000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Sunovion Pharmaceuticals Inc. · 2008-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Net Income: 515110000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: 515110000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-09-001949.txt#12646 The citation records this snapshot. The page link may show a newer release later.	USD 162.76 million Exact value Exact value: 162757000 USD 2008-01-01 – 2008-12-31: 162757000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Sunovion Pharmaceuticals Inc. · 2008-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Operating Cash Flow: 162757000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 162757000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-09-001949.txt#12920 The citation records this snapshot. The page link may show a newer release later.	USD 49.62 million Exact value Exact value: 49615000 USD 2008-01-01 – 2008-12-31: 49615000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Sunovion Pharmaceuticals Inc. · 2008-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Capital Expenditure: 49615000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 49615000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-09-001949.txt#13026 The citation records this snapshot. The page link may show a newer release later.	USD 113.14 million Calculation and evidence 162757000 − 49615000 USD Exact free cash flow: 113142000 USD 2008-01-01 – 2008-12-31: 162757000 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 49615000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Sunovion Pharmaceuticals Inc. · 2008-12-31 Sunovion Pharmaceuticals Inc. (edgar:877357) Free cash flow: 113142000 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T20:17:35Z Snapshot: fb4b1c50006d060a8dc23cb5a7b4f3b9c86648e54628a15b8873e0683f4ac3cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/877357?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 162757000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-09-001949.txt#12920 Input fundies:CapitalExpenditure: 49615000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/877357/0001047469-09-001949.txt#13026 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

70 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000877357, 877357, edgar:877357

Also known as SEPRACOR INC /DE/

Sunovion Pharmaceuticals Inc.

Latest quarter

Revenue

Operating margin

Trailing twelve months

Revenue

Net income

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2008 2008-01-01 – 2008-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation